Interventional, Randomised, Partially Double-blind, Crossover, Positive-controlled, Single-dose Trial Investigating the Effect of LEO 152020 on Cardiac Repolarisation in Healthy Men and Women
Latest Information Update: 24 Apr 2024
Price :
$35 *
At a glance
- Drugs Izuforant (Primary) ; Moxifloxacin
- Indications Eczema
- Focus Adverse reactions
- Sponsors JW Pharmaceutical; LEO Pharma
- 05 Jan 2023 Status changed from recruiting to completed.
- 24 Oct 2022 Planned End Date changed from 1 Oct 2022 to 1 Nov 2022.
- 24 Oct 2022 Planned primary completion date changed from 1 Oct 2022 to 1 Nov 2022.